These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33387029)

  • 1. Association between maternal triglycerides and disturbed glucose metabolism in pregnancy.
    Eppel D; Feichtinger M; Lindner T; Kotzaeridi G; Rosicky I; Yerlikaya-Schatten G; Eppel W; Husslein P; Tura A; Göbl CS
    Acta Diabetol; 2021 Apr; 58(4):459-465. PubMed ID: 33387029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes.
    Selen DJ; Edelson PK; James K; Corelli K; Hivert MF; Meigs JB; Thadhani R; Ecker J; Powe CE
    Am J Obstet Gynecol; 2022 Feb; 226(2):241.e1-241.e14. PubMed ID: 34419453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism.
    Lowe WL; Scholtens DM; Kuang A; Linder B; Lawrence JM; Lebenthal Y; McCance D; Hamilton J; Nodzenski M; Talbot O; Brickman WJ; Clayton P; Ma RC; Tam WH; Dyer AR; Catalano PM; Lowe LP; Metzger BE;
    Diabetes Care; 2019 Mar; 42(3):372-380. PubMed ID: 30655380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism.
    Scholtens DM; Kuang A; Lowe LP; Hamilton J; Lawrence JM; Lebenthal Y; Brickman WJ; Clayton P; Ma RC; McCance D; Tam WH; Catalano PM; Linder B; Dyer AR; Lowe WL; Metzger BE; ;
    Diabetes Care; 2019 Mar; 42(3):381-392. PubMed ID: 30617141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance.
    Benhalima K; Van Crombrugge P; Moyson C; Verhaeghe J; Vandeginste S; Verlaenen H; Vercammen C; Maes T; Dufraimont E; De Block C; Jacquemyn Y; Mekahli F; De Clippel K; Van Den Bruel A; Loccufier A; Laenen A; Minschart C; Devlieger R; Mathieu C
    Diabetologia; 2019 Nov; 62(11):2118-2128. PubMed ID: 31338546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes.
    Retnakaran R; Ye C; Kramer CK; Connelly PW; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2016 Jul; 39(7):1250-8. PubMed ID: 27208323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria.
    Benhalima K; Jegers K; Devlieger R; Verhaeghe J; Mathieu C
    PLoS One; 2016; 11(6):e0157272. PubMed ID: 27285104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gestational diabetes mellitus (Update 2019)].
    Kautzky-Willer A; Harreiter J; Winhofer-Stöckl Y; Bancher-Todesca D; Berger A; Repa A; Lechleitner M; Weitgasser R
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):91-102. PubMed ID: 30980150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM).
    O'Malley EG; Reynolds CME; Killalea A; O'Kelly R; Sheehan SR; Turner MJ
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():67-71. PubMed ID: 31962258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked decline in beta cell function during pregnancy leads to the development of glucose intolerance in Japanese women.
    Saisho Y; Miyakoshi K; Ikenoue S; Kasuga Y; Matsumoto T; Minegishi K; Yoshimura Y; Itoh H
    Endocr J; 2013; 60(4):533-9. PubMed ID: 23292170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy.
    Retnakaran R; Kramer CK; Ye C; Kew S; Hanley AJ; Connelly PW; Sermer M; Zinman B
    Diabetes Care; 2015 May; 38(5):844-51. PubMed ID: 25693837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postpartum abnormal glucose metabolism subtype differs according to mid-trimester lipid profile in women with gestational diabetes mellitus.
    Lai F; Li Z; Yue S; Pei L; Xiao H; Li Z; Li Y; Xiao H; Cao X
    Lipids Health Dis; 2021 Aug; 20(1):91. PubMed ID: 34429117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nutrition therapy for glucose intolerance in Japanese women diagnosed with gestational diabetes based on IADPSG criteria during early gestation.
    Horie I; Kawasaki E; Sakanaka A; Takashima M; Maeyama M; Ando T; Hanada H; Kawakami A
    Diabetes Res Clin Pract; 2015 Mar; 107(3):400-6. PubMed ID: 25631609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of cardiovascular risk factors and insulin resistance 6 years after hyperglycemia first detected in pregnancy in Cape Town, South Africa.
    Chivese T; Norris SA; Levitt NS
    BMJ Open Diabetes Res Care; 2019; 7(1):e000740. PubMed ID: 31803480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
    Chen Y; Du M; Xu J; Chen D
    Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gestational diabetes mellitus].
    Kautzky-Willer A; Harreiter J; Bancher-Todesca D; Berger A; Repa A; Lechleitner M; Weitgasser R
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S103-12. PubMed ID: 27052232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus.
    Disse E; Graeppi-Dulac J; Joncour-Mills G; Dupuis O; Thivolet C
    Diabetes Metab; 2013 Apr; 39(2):132-8. PubMed ID: 23182459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point.
    Mendoza LC; Harreiter J; Simmons D; Desoye G; Adelantado JM; Juarez F; Chico A; Devlieger R; van Assche A; Galjaard S; Damm P; Mathiesen ER; Jensen DM; Andersen LLT; Tanvig M; Lapolla A; Dalfra MG; Bertolotto A; Mantaj U; Wender-Ozegowska E; Zawiejska A; Hill D; Jelsma JG; Snoek FJ; van Poppel MNM; Worda C; Bancher-Todesca D; Kautzky-Willer A; Dunne FP; Corcoy R
    Eur J Endocrinol; 2018 Jul; 179(1):39-49. PubMed ID: 29739812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status.
    Maple-Brown L; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4148-55. PubMed ID: 22948759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.